Elekta ABEKTAF +3.17%77 Interest Coverage is 0 (At Loss) as of Apr. 2026. GuruFocus rates EKTAF with a GF Score™ of 77/100 and a GF Value™ of $6.07 (Modestly Undervalued). The stock has 6 warning signs investors should review. Among 466 Medical Devices & Instruments companies, Elekta AB ranks worse than 97.85% on this metric.
Interest Coverage is a ratio that determines how easily a company can pay interest expenses on outstanding debt. It is calculated by dividing a company's
Operating Income
by its Interest Expense. Elekta AB's
Operating Income
for the
three
months ended in Apr. 2026 was $-57 Mil. Elekta AB's Interest Expense for the
three
months ended in Apr. 2026 was $-13 Mil.
did not have earnings to cover the interest expense.
The higher the ratio, the stronger the company's financial strength is.
The historical rank and industry rank for Elekta AB's Interest Coverage or its related term are showing as below:
EKTAF'
s Interest Coverage Range Over the Past 10 Years
Min: 0.27 Med: 7.04 Max: 11.38
Current: 0.28
EKTAF's Interest Coverage is ranked worse than 97.85% of 466
companies
in the Medical Devices & Instruments industry
Industry Median: 15.875
vs EKTAF: 0.28
Elekta AB (OTCPK:EKTAF) Interest Coverage Explanation
Ben Graham requires that a company has a minimum interest coverage of 5 with the companies he invested. If the interest coverage is less than 2, the company is burdened by debt. Any business slow or recession may drag the company into a situation where it cannot pay the interest on its debt.
Interest Coverage is an important factor when GuruFocus ranks a company's overage Financial Strength .
Elekta AB Interest Coverage Related Terms
Elekta AB Interest Coverage Historical Data
* Premium members only.
The historical data trend for Elekta AB's Interest Coverage can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Note: For Interest Coverage, "No debt" indicates no long-term debt. An indication of "No Debt" does not necessarily mean that the company has no long-term debt obligations; it could be due to missing data in the quarterly or annual report. Use caution when interpreting this information.
EKTAF vs ABT, SYK, MDT: Interest Coverage Comparison
For the Medical Devices subindustry, Elekta AB's Interest Coverage, along with its competitors' market caps and Interest Coverage data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Elekta AB Interest Coverage vs Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, Elekta AB's Interest Coverage distribution charts can be found below:
* The bar in red indicates where Elekta AB's Interest Coverage falls into.
Interest Coverage is a ratio that determines how easily a company can pay interest expenses on outstanding debt. It is calculated by dividing a company's Operating Income (EBIT) by its Interest Expense:
Elekta AB did not have earnings to cover the interest expense.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
What does a Interest Coverage of 0 (At Loss) mean?
Elekta AB (EKTAF) has a Interest Coverage of 0 (At Loss) as of Apr. 2026. Interest Coverage measures a company's capability to pay interest expenses on its debt. View historical data on Elekta AB and its competitors. Over the past decade, Elekta AB's Interest Coverage has ranged from 0.27 to 11.38. According to the industry distribution chart, Elekta AB ranks #456 out of 466 companies in the Medical Devices & Instruments industry, placing it in the top 97.9%.
Is Elekta AB's Interest Coverage too high?
Elekta AB's current Interest Coverage is 0 (At Loss). Over the past 10 years, this metric has ranged from a low of 0.27 to a high of 11.38. Based on the distribution chart, Elekta AB ranks #456 out of 466 companies in the Medical Devices & Instruments industry, which is in the bottom quartile relative to peers. Overall, Elekta AB has a GF Score™ of 77/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Elekta AB's Interest Coverage compare to ABT and SYK?
According to the Medical Devices & Instruments industry distribution chart, Elekta AB ranks #456 out of 466 companies for Interest Coverage. This places Elekta AB in the lower half of its industry. The industry median Interest Coverage is 15.88. Historically, Elekta AB's own Interest Coverage has ranged from 0.27 to 11.38 over the past decade. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Interest Coverage for a Medical Devices & Instruments company?
The median Interest Coverage among Medical Devices & Instruments companies is 15.88, based on 466 companies in the industry. Companies in the top quartile (top 25%) have a Interest Coverage significantly above this median, while those in the bottom quartile fall well below. However, Interest Coverage should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Interest Coverage mean?
A high Interest Coverage can signal that a stock is expensive relative to its fundamentals. Interest Coverage measures a company's capability to pay interest expenses on its debt. View historical data on Elekta AB and its competitors. For the Medical Devices & Instruments industry, the median Interest Coverage is 15.88 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Elekta AB's current Interest Coverage is 0 (At Loss). However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Elekta AB stock overvalued right now?
Based on GuruFocus' analysis, Elekta AB (EKTAF) is currently considered Modestly Undervalued. The stock's GF Value™ is $6.07, compared to a current price of $5.04 — trading 17% below its estimated fair value. The current Interest Coverage is 0 (At Loss). Elekta AB's overall GF Score™ is 77/100 with 6 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Interest Coverage calculated?
Interest Coverage is calculated from a company's financial statements. For Elekta AB (EKTAF), the current Interest Coverage is 0 (At Loss) as of Apr. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Elekta AB (EKTAF) Overvalued in 2026?
Based on GuruFocus' analysis, Elekta AB stock appears to be undervalued.
The current stock price of $5.04 is trading 17% below its estimated GF Value™ of $6.07.
GuruFocus considers Elekta AB to be Modestly Undervalued.
Key valuation signals for EKTAF:
Interest Coverage: 0 (At Loss)
GF Value™: $6.07 vs. price of $5.04 (17% below fair value)
No single metric tells the full story. See the EKTAF stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Sweden-based Elekta develops, manufactures, and distributes treatment planning systems for neurosurgery and radiotherapy, including stereotactic radiosurgery and brachytherapy. The company has an installed base of more than 7,300 linear accelerators, Gamma Knife and Unity platforms, as well as brachytherapy installations. The company's sales are evenly distributed across geographies, with North and South America accounting for 29%; Europe, the Middle East, and Africa accounting for 37%; and the Asia-Pacific contributing the remainder.
77GF Score
Get the complete analysis for EKTAF
Interest Coverage is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
EKTAF has been successfully added to your 
